1. Home
  2. ACLX vs PCH Comparison

ACLX vs PCH Comparison

Compare ACLX & PCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACLX
  • PCH
  • Stock Information
  • Founded
  • ACLX 2015
  • PCH 1903
  • Country
  • ACLX United States
  • PCH United States
  • Employees
  • ACLX N/A
  • PCH N/A
  • Industry
  • ACLX Biotechnology: Pharmaceutical Preparations
  • PCH Real Estate Investment Trusts
  • Sector
  • ACLX Health Care
  • PCH Real Estate
  • Exchange
  • ACLX Nasdaq
  • PCH Nasdaq
  • Market Cap
  • ACLX 3.8B
  • PCH 3.2B
  • IPO Year
  • ACLX 2022
  • PCH N/A
  • Fundamental
  • Price
  • ACLX $71.39
  • PCH $40.89
  • Analyst Decision
  • ACLX Strong Buy
  • PCH Strong Buy
  • Analyst Count
  • ACLX 14
  • PCH 7
  • Target Price
  • ACLX $114.75
  • PCH $49.86
  • AVG Volume (30 Days)
  • ACLX 400.2K
  • PCH 594.9K
  • Earning Date
  • ACLX 08-11-2025
  • PCH 07-28-2025
  • Dividend Yield
  • ACLX N/A
  • PCH 4.26%
  • EPS Growth
  • ACLX N/A
  • PCH 15.06
  • EPS
  • ACLX N/A
  • PCH 0.53
  • Revenue
  • ACLX $76,809,000.00
  • PCH $1,056,523,000.00
  • Revenue This Year
  • ACLX N/A
  • PCH $2.63
  • Revenue Next Year
  • ACLX $108.81
  • PCH $4.86
  • P/E Ratio
  • ACLX N/A
  • PCH $79.94
  • Revenue Growth
  • ACLX N/A
  • PCH N/A
  • 52 Week Low
  • ACLX $47.86
  • PCH $36.82
  • 52 Week High
  • ACLX $107.37
  • PCH $48.12
  • Technical
  • Relative Strength Index (RSI)
  • ACLX 59.78
  • PCH 51.65
  • Support Level
  • ACLX $69.30
  • PCH $40.31
  • Resistance Level
  • ACLX $74.43
  • PCH $43.80
  • Average True Range (ATR)
  • ACLX 2.58
  • PCH 1.19
  • MACD
  • ACLX 0.06
  • PCH 0.03
  • Stochastic Oscillator
  • ACLX 61.57
  • PCH 28.15

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

About PCH PotlatchDeltic Corporation

PotlatchDeltic Corp is a REIT that owns and manages forestland in Alabama, Arkansas, Idaho, Minnesota, and Mississippi. Potlach operates in three segments. The timberlands segment covers the planting and harvesting of trees, as well as the construction and maintenance of roads. The wood products segment manufactures and distributes lumber, plywood, and other wood products. The real estate segment covers the sales generated from company-owned timberlands, as well as commercial and residential properties. The timberlands and the wood product segments combined drive the majority of the company's revenue.

Share on Social Networks: